X0708 D LIVE 0001671502 Quoin Pharmaceuticals Ltd. 42127 PLEASANT FOREST COURT ASHBURN VA VIRGINIA 20148-7349 (703) 980-4182 ISRAEL None Quoin Pharmaceuticals, Ltd. Cellect Biotechnology Ltd. Cellect Biomed Ltd. Corporation true Michael Myers 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Executive Officer Director Sally Bridget Lawlor 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Executive Officer Denise Carter 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Executive Officer Director Joseph Cooper 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director James Culverwell 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director Dennis Langer 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director Natalie Leong 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director Michael Sember 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director Pharmaceuticals Decline to Disclose 06b false 2026-08-31 false true true true false 0 Leerink Partners LLC 000039011 None None 1301 Avenue of the Americas 5th Floor New York NY NEW YORK 10019 CA CALIFORNIA CT CONNECTICUT DE DELAWARE FL FLORIDA MD MARYLAND NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OR OREGON true BTIG, LLC 000122225 None None 65 East 55th Street New York NY NEW YORK 10022 CA CALIFORNIA CT CONNECTICUT DE DELAWARE FL FLORIDA MD MARYLAND NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OR OREGON true Lake Street Capital Markets, LLC 000164447 None None 121 South 8th Street Suite 1000 Minneapolis MN MINNESOTA 55402 CA CALIFORNIA CT CONNECTICUT DE DELAWARE FL FLORIDA MD MARYLAND NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OR OREGON true 50000649 50000649 0 The total offering amount reflects the total gross proceeds to be received assuming cash exercise of all warrants issued in the private placement. false 33 3000039 true 0 Consists of fees due to placement agents equal in aggregate to 6.0% of gross offering proceeds, assuming cash exercise of all warrants issued. Lead placement agent also entitled to reimbursement for reasonable out-of-pocket expenses, not included here. 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false Quoin Pharmaceuticals Ltd. /s/ Sally Lawlor Sally Lawlor Chief Financial Officer 2026-09-10